Fortress Biotech, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FBIO research report →
Companywww.fortressbiotech.com
Fortress Biotech, Inc. , a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne.
- CEO
- Lindsay Allan Rosenwald
- IPO
- 2011
- Employees
- 101
- HQ
- Bay Harbor Islands, FL, US
Price Chart
Valuation
- Market Cap
- $85.50M
- P/E
- 0.66
- P/S
- 1.29
- P/B
- 0.52
- EV/EBITDA
- 21.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 64.51%
- Op Margin
- -84.36%
- Net Margin
- 193.12%
- ROE
- 163.88%
- ROIC
- -20.91%
Growth & Income
- Revenue
- $63.26M · 9.69%
- Net Income
- $6.82M · 114.82%
- EPS
- $-0.07 · 97.49%
- Op Income
- $-70,221,000
- FCF YoY
- 30.90%
Performance & Tape
- 52W High
- $4.53
- 52W Low
- $1.67
- 50D MA
- $2.58
- 200D MA
- $2.94
- Beta
- 1.16
- Avg Volume
- 705.73K
Get TickerSpark's AI analysis on FBIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 1, 26 | Jin David | other | 2,967 |
| Mar 18, 26 | ROSENWALD LINDSAY A MD | other | 475,424 |
| Mar 18, 26 | WEISS MICHAEL S | other | 475,424 |
| Jan 1, 26 | Klein Dov | other | 27,322 |
| Jan 1, 26 | Harvey Jimmie | other | 27,322 |
| Jan 1, 26 | Lorenz Kevin | other | 27,322 |
| Jan 1, 26 | Hoenlein Malcolm | other | 27,322 |
| Jan 1, 26 | LOBELL J JAY | other | 27,322 |
| Oct 1, 25 | Jin David | other | 2,711 |
| Apr 1, 25 | Jin David | other | 5,000 |
Our FBIO Coverage
We haven't published any research on FBIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FBIO Report →